← Browse by Condition
Medical Condition
radial artery occlusion
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for radial artery occlusion sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
NCT06981624
Recruiting
Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion
Enrollment
500 pts
Location
Canada
Sponsor
Olivier F. Bertrand
NCT03630055 Phase 3
Recruiting
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
Enrollment
1,800 pts
Location
United States, Canad...
Sponsor
Ottawa Heart Institute Researc...
NCT06812455 Phase 4
Recruiting
Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization
Enrollment
80 pts
Location
Greece
Sponsor
AHEPA University Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology